Figure 3.

Kaplan-Meier analysis of days to CV event in SPAA and CCB/statin primary prevention patients with no history of cancer or chronic renal failure

Chapman et al. BMC Cardiovascular Disorders 2010 10:29   doi:10.1186/1471-2261-10-29
Download authors' original image